Top Markets
#1 Islamic Coin Islamic Coin +155.97%
#2 Siren Siren +37.56%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.25%
#4 Verus Coin Verus Coin +22.40%
#5 Cysic Cysic +19.84%
#6 Arowana Arowana +19.40%
#7 OpenEden OpenEden +17.23%
#8 Perle Perle +14.78%
#9 Ocean Protocol Ocean Protocol +13.13%
#10 RedStone RedStone +12.61%
Coin of the day
Islamic Coin Islamic Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
Kedudukan dalam Saham #31791
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
Harga Saham
$0.21291741
Disegerakkan terakhir: 2025-04-18
Modal Pasaran
$12.07M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
KR
Perdagangan PCL, Inc. (241820)

Kategori

Healthcare
Hasil untuk PCL, Inc. (241820)
Hasil pada Sep 2025 TTM: $3.55M
Menurut laporan kewangan terkini daripada PCL, Inc., hasil semasa syarikat (TTM) ialah $3.55M. Pada tahun 2023, syarikat memperoleh hasil sebanyak $6.51M penurunan berbanding hasil pada tahun 2022 iaitu $29.49M. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi PCL, Inc. dari 2015 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
2026 (TTM) $3.55M 318.67%
2024 $847.63K -86.98%
2023 $6.51M -77.92%
2022 $29.49M -24.02%
2021 $38.82M -21.50%
2020 $49.45M 159,346.74%
2019 $31.01K -73.14%
2018 $115.44K -75.69%
2017 $474.92K -2.74%
2016 $488.29K 136.13%
2015 $206.79K 0.00%
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 1,312,601.74%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 727,951.41%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 999,790.71%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 591,538.63%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B 183,407.73%
US